Total trials
144
Active
21
Phase 3
0
Total enrollment
14,057
Pipeline matrix
Showing 1 of 1 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Pyridoxal-5'-Phosphate supplement | — | — | — | — | — | 1 |
Next readouts
- 2026-11
Top conditions
- Healthy15
- Mood12
- Cardiovascular Disease10
- Cognition8
- Cognitive Change6
- Individual Difference5
- Food Sensitivity5
- Food Preferences5
Frequently asked questions about University of Reading
- How many clinical trials does University of Reading have on ClinicalTrials.gov?
- University of Reading is listed as the lead sponsor on 144 clinical trials in ClinicalTrials.gov, 21 of which are currently active (recruiting, enrolling, or ongoing).
- How many of University of Reading's trials are in Phase 3?
- 0 of University of Reading's trials are in Phase 3, spread across 1 active drug program.
- What therapeutic areas does University of Reading focus on?
- University of Reading's most-studied conditions on ClinicalTrials.gov are Healthy, Mood, Cardiovascular Disease, Cognition, Cognitive Change.
- When are University of Reading's next clinical trial readouts?
- University of Reading has 1 upcoming primary-completion readout tracked here; the soonest is “The Effects of High-dose Vitamin B6 on Depression and Anxiety Symptoms”, expected around 2026-11.